Cochrane News

Most widely followed COPD guideline updates their recommendations with Cochrane Airways reviews

21 hours 38 minutes ago

The recently updated GOLD report includes evidence from 7 Cochrane Airways systematic reviews, helping to align it with the latest and best available evidence.  

Chronic obstructive lung disease (COPD) is usually caused by smoking or other airway irritants. COPD damages the lungs and causes airways to narrow which makes it difficult to breathe.

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) works with healthcare professionals and public health officials worldwide to raise awareness of COPD and improve the prevention and treatment of this lung disease. The GOLD strategy document for diagnosing, managing, and preventing COPD and the corresponding pocket guide is developed for healthcare professionals based on the best scientific information available. This global evidence-based document is used as a tool to implement effective management programs based on local healthcare systems around the world.


"The GOLD Report is the most widely accepted and followed COPD guideline," explains Emma Jackson, Managing Editor of Cochrane Airways. "We were pleased to see that 7 Cochrane Airways systematic reviews were added to the GOLD Report 2023 recommendations for the first time; over 35 Cochrane Reviews are already referenced in the GOLD Report."

"Cochrane is a not-for-profit organization with collaborators from more than 190 countries working together to produce credible, accessible health information that is free from commercial sponsorship and other conflicts of interest,” says Rebecca Fortescue, Co-ordinating Editor for Cochrane Airways Editor. “Cochrane Reviews are known as the ‘gold standard’ when it comes to health evidence synthesis. We are delighted to see that 7 Cochrane Airway reviews were added in the 2023 GOLD Report to help align clinical practice with the latest and best available evidence.”

The seven reviews included in the 2023 Report for the first time are:

Lead author of the review on dual combination inhaler therapy, Yuji Oba says, “COPD is the third leading cause of death worldwide. Inhaler therapy is the mainstay treatment of COPD and the choice of inhalers is of paramount importance for patients and healthcare providers. The 2018 Cochrane review addressed which inhaler was the most efficacious and safe in the advanced form of COPD. We are proud to see the GOLD Report was updated and modified the first choice of inhaler treatment based on our Cochrane review. We are currently updating this Cochrane review and are looking forward to having our work contribute to future GOLD Reports." 

Wednesday, February 8, 2023 Category: The difference we make
Muriah Umoquit

Cochrane seeks Internal Communications Manager

2 days 22 hours ago

Title: Internal Communications Manager
Specifications:
Permanent – Full Time
Salary:
£52,508
Location:
Ideally based in the UK, Germany or Denmark. Candidates from the rest of the world will be considered; however, Cochrane’s Central Executive Team is only able to offer consultancy contracts outside these countries (1-year fixed-term contracts)
Directorate: Development
Closing date:
20 Feb 2023

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters from more than 220 countries. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into five directorates: Evidence Production and Methods, Publishing and Technology, Development, and Finance and Corporate Services.

This is an exciting opportunity to build a new function from the ground up, as Cochrane’s first dedicated internal communications role. The first priority for this role will be to establish effective internal communications structures and processes for Cochrane’s~100 core staff, who are distributed across multiple countries and time zones. This includes developing an intranet and regular staff communications.

Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values: Collaboration: Underpins everything we do, locally and globally. Relevant: The right evidence at the right time in the right format. Integrity: Independent and transparent. Quality: Reviewing and improving what we do, maintaining rigour and trust.

You can expect:

  • An opportunity to truly impact health globally
  • A flexible work environment
  • A comprehensive onboarding experiences
  • An environment where people feel welcome, heard, and included, regardless of their differences

Cochrane welcomes applications from a wide range of perspectives, experiences, locations and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

  • For further information on the role and how to apply, please click here.
  • The deadline to receive your application is 20 Feb 2023.
  • The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples.
  • Read our Recruitment Privacy Statement
Monday, February 6, 2023 Category: Jobs
Lydia Parsonson

Cochrane seeks Future of Evidence Synthesis Administrative Support Officer

2 days 22 hours ago

Title: Future of Evidence Synthesis Administrative Support Officer
Specifications:
Fixed Term – 2 Years
Location:
UK – Remote/Flexible
Salary:
£27,071
Directorate:
Evidence Production & Methods
Closing date:
20 Feb 2023

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters from more than 220 countries. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into five directorates: Evidence Production and Methods, Publishing and Technology, Development, and Finance and Corporate Services.

The Future of Evidence Synthesis (FES) is a critical programme of work for Cochrane over the next 3-5 years. Successful delivery is essential is Cochrane to achieve the Strategy for Change objectives and become a sustainable organisation. This role provides effective and efficient administrative support for the FES programme generally and supports the pilot phase of the Thematic Group pilot specifically.

Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values: Collaboration: Underpins everything we do, locally and globally. Relevant: The right evidence at the right time in the right format. Integrity: Independent and transparent. Quality: Reviewing and improving what we do, maintaining rigour and trust.

You can expect:

  • An opportunity to truly impact health globally
  • A flexible work environment
  • A comprehensive onboarding experiences
  • An environment where people feel welcome, heard, and included, regardless of their differences

Cochrane welcomes applications from a wide range of perspectives, experiences, locations and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

  • For further information on the role and how to apply, please click here
  • The deadline to receive your application is 20 Feb 2023.
  • The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples.
  • Read our Recruitment Privacy Statement
Monday, February 6, 2023 Category: Jobs
Lydia Parsonson

Early registration now open for Cochrane London 2023

6 days 19 hours ago

Registration is now open for the 2023 Cochrane Colloquium. Register before the 01 June 2023 to get the reduced early bird rate

You can now register for the Cochrane Colloquium, which will take place at the Queen Elizabeth II (QEII) Centre in London from 4th to 6th September 2023, with Satellite events on 3rd September.

The Colloquium is an annual event for everyone with an interest in the use of evidence in healthcare decision making including those engaged in evidence production, co-production, dissemination, implementation and policy making, as well as those making individual healthcare decisions.

This year’s theme is ‘Forward together for trusted evidence’. It will explore the challenges for the future around the trustworthiness of healthcare data and information whilst also celebrating 30 years of producing trusted evidence. 

Students, healthcare consumers, and people from low-income, lower-middle-income, and upper-middle-income economies (LMIC) are eligible for a reduced rate.

As well as now being able to register, you can submit an abstract or submit a workshop for the event.

We look forward to welcoming you to London!

Register today: Further information Monday, February 6, 2023
Muriah Umoquit

Cochrane review finds that vitamin D does not reduce risk of asthma attacks

1 week 1 day ago

Taking vitamin D supplements does not reduce the risk of asthma attacks in children or adults, according to an updated Cochrane review.

These findings are in contrast to a previous Cochrane review that indicated a reduction in asthma attacks in people taking vitamin D. However, the review found no harm in taking vitamin D and it did not examine other possible health benefits.

The review was carried out by researchers from Queen Mary University of London and the University of Edinburgh. Researcher Adrian Martineau, Clinical Professor of Respiratory Infection and Immunity at Queen Mary University of London, said: “Vitamin D deficiency has been linked to an increased risk of severe asthma attacks and our previous Cochrane review, published in 2016, found that vitamin D reduced the risk of asthma attacks. However, more studies have been published since then and when we included the extra data in our updated review, the overall results changed. We found that vitamin D supplements had no effect on risk of asthma attacks or on control of asthma symptoms compared with a placebo.”

Professor Martineau and his colleagues analysed the results of 20 randomised controlled trials – the gold-standard for medical research – including data on 1,155 children and 1,070 adults with asthma. This compares to nine trials involving a total of 1,093 people whose data contributed to the previous review. The majority of patients in the trials had mild to moderate asthma.

When they compared patients who were assigned to take a vitamin D supplement with patients who were assigned to take a placebo (dummy medication), the researchers found no statistically significant difference in the number of people who experienced an asthma attack requiring treatment with a course of steroid tablets.

The review did not find any effect of taking vitamin D on asthma control even when people were vitamin D-deficient when they joined the studies, or with different doses of the supplement, or in people of different ages.

Professor Martineau said: “In contrast to our previous Cochrane review on this topic, this updated review does not find that vitamin D offers protection against asthma attacks or improves control of asthma symptoms. However, the trials we looked at did not include many people with severe asthma or people with very low levels of vitamin D in their blood, so these are areas where more research is still needed."

Anne Williamson, the first author on the study who is also from Queen Mary University of London, commented: “We can’t be certain why this updated review has given a different result to our original study from 2016. It could be that people with asthma may be getting better treatment than previously. Or it could be that, in general, rates of vitamin D deficiency have decreased over time, due to increasing intake of supplements or fortified foods. Either of these factors could obscure potential benefits from taking vitamin D supplements. Regardless of the reason, these most recent findings are likely to be correct for people living with asthma today.

This also highlights why it’s vital to update reviews when more research is published.”

Today’s review includes data from 20 clinical trials, compared with nine in the 2016 review, and children with asthma are better represented than previously. The review team say they have also applied stricter criteria on which studies would be included, compared to some other reviews. For example, they excluded studies that did not compare vitamin D with a placebo and those that did not monitor patients for at least 12 weeks.

Most of the trials included in the review involved patients taking cholecalciferol, which is the typical form of vitamin D supplement. One trial that used calcidiol, which is a compound that the body can make from vitamin D, reported an improvement in asthma control in patients taking this supplement. The reviewers say further research is needed to confirm whether this form of vitamin D has benefits for people with asthma.

Williamson A, Martineau AR, Sheikh A, Jolliffe D, Griffiths CJ. Vitamin D for the management of asthma. Cochrane Database of Systematic Reviews 2023, Issue 2. Art. No.: CD011511. DOI: 10.1002/14651858.CD011511.pub3.

Monday, February 6, 2023
Muriah Umoquit

Cochrane London 2023: Call for abstracts now open

1 week 6 days ago

Cochrane London 2023: Forward together for trusted evidence
4-6 September 2023
Central London, UK

Cochrane UK is delighted to be hosting the  Cochrane Colloquium at the Queen Elizabeth II (QEII) Centre in London, UK from the 4 to 6 of September 2023, with satellite events and meetings on the 3rd September.

Cochrane holds an annual conference, known as a Colloquium, that brings together Cochrane researchers, clinical professionals, early career professionals, patients and carers, policymakers, and anyone interested in evidence synthesis and evidence-based healthcare. The events are a mix of keynote speakers, training opportunities, workshops, presentations, and a lively social and networking atmosphere. They are an exciting opportunity for a community of evidence synthesis enthusiasts to share, learn, and connect.  

Today, 30 January 2023, the call for abstracts has opened. The deadline for submissions is Wednesday, 1 March 2023. 

The theme of the Colloquium is 'Forward together for trusted evidence', which explores the challenges for the future around the trustworthiness of healthcare information whilst also celebrating 30 years of producing trusted evidence. 

We invite abstract submissions for the following streams: producing trusted evidence; advocating for trusted evidence; informing health and care decisions; and co-production and working together. 

We recognize that everything Cochrane does is about and for patients and other health consumers. We ask that all abstract submissions consider the impact on patients and healthcare consumers. In particular, we welcome submissions that are co-produced, co-presented or co-designed with patients or other healthcare consumers.

If you are planning to submit an abstract, please see our guidance and recommendations:

 Catherine Spencer, Cochrane CEO said, “The Cochrane Colloquium will bring people together in one place to discuss, develop and promote Cochrane’s work. I am looking forward to a packed programme at my first Colloquium and encourage you to submit your contributions now.”

Martin Burton, Director of Cochrane UK, said: “We look forward to receiving your abstract submissions for London 2023. You can now submit abstracts for posters, oral presentations, or workshops – and we have guidance to help you.” 

We invite everyone to visit the Colloquium website for all information related to the Colloquium as it's released, including submissions for abstracts and awards/prizes, registration, stipend applications, and the event programme.

 

Monday, January 30, 2023
Muriah Umoquit

Cochrane seeks Head of Fundraising

2 weeks ago

Title: Head of Fundraising
Specifications: Permanent – Full Time
Salary: £60K per annum
Location: Ideally based in the UK, Germany or Denmark. Candidates from the rest of the world will be considered; however, Cochrane’s Central Executive Team is only able to offer consultancy contracts outside these countries (1-year fixed-term contracts)
Directorate: Development
Closing date: 21 Feb, 2023

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters from more than 220 countries. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into five directorates: Evidence Production and Methods, Publishing and Technology, Development, and Finance and Corporate Services.

The Head of Fundraising will lead a small and dedicated team to provide the necessary vision, leadership, and fundraising skills which will enable the organisation to achieve its fundraising targets and organisational Development Strategy. They will have substantial international fundraising and management experience, a talent for building relationships and a proven track record in securing funds from international institutions, statutory sources, major international trusts and foundations, and major donors.

Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values: Collaboration: Underpins everything we do, locally and globally. Relevant: The right evidence at the right time in the right format. Integrity: Independent and transparent. Quality: Reviewing and improving what we do, maintaining rigour and trust.

You can expect:

  • An opportunity to truly impact health globally
  • A flexible work environment
  • A comprehensive onboarding experiences
  • An environment where people feel welcome, heard, and included, regardless of their differences

Cochrane welcomes applications from a wide range of perspectives, experiences, locations and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

  • For further information on the role and how to apply, please click here.
  • The deadline to receive your application is 21st Feb, 2023.
  • The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples.
  • Read our Recruitment Privacy Statement
Wednesday, January 25, 2023 Category: Jobs
Lydia Parsonson

What health evidence can we trust when we need it most?

2 weeks 1 day ago

Dr Jenny McSharry, Health Psychologist and lecturer in the School of Psychology at the University of Galway, explains what systematic reviews are and why they are a particularly trustworthy source of health evidence. 

Dr Jenny Mc Sharry was supported by an Evidence Synthesis Ireland Writing Mentorship (Grant code ESI-2021-001) and this blog post was originally posted on Evidently Cochrane.

When we are diagnosed with a new condition, experience a worrying symptom or need to make a health decision for ourselves or our loved ones, it can be hard to know where to turn. How often have we found ourselves unable to sleep, alone at 3AM, searching online for answers to questions we never thought we would have to ask?  In times of anxiety and uncertainty, how can we know what health evidence to trust when we need it most?

When looking for reliable information to help with health decisions, reviews of evidence, in particular systematic reviews, can be a good place to start.

Systematic reviews of multiple studies can be useful for health decisions

Reviews that bring together and summarise the existing evidence are more reliable than one research study, or one person’s opinion or experience. Lots of things can affect the findings of a research study and we can have more confidence in reviews that bring together lots of studies. There is more information on why Personal experiences or anecdotes (stories) are an unreliable basis for assessing the effects of most treatments on the Evidently Cochrane blog.

Systematic reviews are seen as the gold-standard of research evidence. A systematic review is a type of review that tries to find, assess, and summarise all the evidence that meets pre-specified criteria to answer a specific question. Researchers who complete systematic reviews follow a number of key steps to make their findings more trustworthy.

Systematic reviews summarise evidence related to a specific question

Systematic reviews look for evidence that might help answer a specific question, and clearly outline this question from the start. For example, a systematic review Antihistamines for motion sickness was done to find out if  medicines used for allergy symptoms (antihistamines) work and are safe in preventing travel (motion) sickness. The review summarises evidence on how antihistamines compare with dummy treatment (placebo), no treatment, and other medicines. This review is useful if you want to find evidence about medicines for travel sickness, but not if you want to know if you should avoid reading or drink ginger tea while travelling. When a review clearly states its focus, it helps us judge whether it is relevant and useful to us.

Systematic reviews aim to find all studies that meet certain criteria

Systematic reviews researchers try to find and include all studies relevant to a specific question. This is important, as we want all relevant information to be available to us when making a health decision. When using evidence from a review to decide if we should start a new treatment for example, we want to be sure that studies that found benefits, studies that found harms, and studies that found little or no difference, are just as likely to have been included.

Systematic review researchers try to find all relevant studies by clearly outlining the sources they will search, and by making a list of the criteria they will use to decide if studies should be included. For example, in our review Video calls for reducing social isolation and loneliness in older people, we wanted to find out if older people who used video calls to keep in touch with family and friends feel less lonely than those who did not. For this review, we needed to decide on what we meant by older adults, as the findings might be different for people aged 65 and older, or people aged 70 and older. For this review, we decided to include studies of people aged 65 and older and made it clear when reporting the findings that this was the group we had focused on.

Systematic review researchers clearly state the methods they will use to identify studies before starting the review. Other researchers should be able to use these methods and find the same set of studies.

Systematic reviews assess and report on the quality of evidence

When reading reviews of evidence, it is important to know how many relevant studies there are, but also to know if the studies are of good quality. Even if a number of studies find that a treatment is beneficial, we may not want to choose this treatment if we find out that the number of people included in the studies was very small, or that the way in which people were identified to take part in the studies was not clear. For a systematic review, researchers assess if the methods used in the included studies were appropriate. Researchers then make a judgement on the level of certainty we can have in the overall evidence, based on whether the included studies were done well or not.

Finding relevant systematic reviews: Where to look?

When it comes to trustworthiness, not all information we find is equal, and it is good to know that systematic reviews can be helpful in making health decisions. However, when feeling anxious about a health condition or symptom, or when trying to make an urgent health decision, it can be hard to know how to find relevant systematic reviews.

Cochrane is an independent global organisation that aims to provide high-quality evidence to inform decisions about health and care. Cochrane systematic reviews are published online in the Cochrane Library. The Cochrane Library is free to access for people in the UK and Ireland (and in many other countries). You can search by topic, and the reviews all have a Plain Language Summary. The blogs here on Evidently Cochrane aim to make health evidence easy to understand and use by providing summaries of Cochrane Reviews in context, often alongside patients’ and health professionals’ experiences. Evidently Cochrane includes an A-Z list of topics to make it easier to search for relevant evidence, and can be a good place to start when supporting family and friends or making choices about our own health.

What else can you do to work out if health information is trustworthy?

If you are interested in finding out more about health information and what we can trust, the blog, Making health decisions: things that can help, looks at some key things to consider to help us to make the right decision and to reduce the risk of regretting our choices later on. The blog also reminds us that summaries of research evidence are just one part of how we make health decisions, and our own preferences and values and the views of healthcare professionals are also very important. The blog includes lots of resources to help you think critically about health information and to support your decision-making.

Tuesday, January 24, 2023
Muriah Umoquit

New Cochrane review on family-centred interventions for Indigenous early childhood well-being by primary healthcare services

3 weeks 1 day ago

Family-centred care is a way of providing care that focuses on the needs of children while providing planned care around the whole family unit. A new Cochrane review published recently found there was a small improvement in the overall health and well-being of Indigenous children and their families when they participated in family-centred care programmes at a primary healthcare service.

‘Family centred-care is not new,’ says lead author Dr Natalie Strobel, Senior Research Fellow at Edith Cowan University’s Centre for Improving Health Services for Aboriginal and Torres Strait Islander Children and Families. ‘Aboriginal Medical Services have been doing this for years. For example, they don’t just immunise babies, they talk to mums, aunts, uncles, grandparents and everybody that’s part of that family unit – trying to ensure that everybody's getting care. That’s both health and social care, so it might be making sure there’s appropriate housing, referrals to services that they needed or for other types of support.’

‘We know that primary healthcare, particularly Indigenous-led services, are well placed to deliver services that reflect the needs of Indigenous children and their families. Of our author team of nine, four are Aboriginal and have worked in health services as nurses and midwives for a long time. Families want primary healthcare services that both support them and recognise Indigenous ways of knowing and doing business. This can be delivered through environmental, communication, educational, counselling, and family support approaches.’

A key finding of this new review was that family-centred care delivered by primary healthcare services may improve the overall health and well-being of children and their families, however, due to a range of factors, the evidence was rated as very low certainty. There was also evidence to suggest that families who participated in family-centred care increased their parenting knowledge and awareness to a small degree. However, for all other outcomes it was unclear whether family-centred care improves specific child health and well-being outcomes. Ultimately more high quality trials are needed to generate evidence to determine whether family-centred care improves the health and well-being of Indigenous children.

‘We consider family-centred care to be really promising, but we’re not confident in the evidence for a range of reasons, which are quite complex,’ Natalie says. ‘For example, people in the studies were aware of what intervention they were getting, many people did not come back to report their results, and not all the studies reported the information we were interested in. Also, some of the issues around low quality of evidence are really hard for communities that are doing this type of work to get around.’

‘For instance, in the United States you're delivering the intervention on a reservation and there's not a huge number of people to do this work. Often the person who delivers the intervention also collects the data. We know that's got a significant level of bias involved in it, but it's also very pragmatic, that's what happens and how it has to work because there's not enough people to complete the project. This highlights the challenges of conducting high quality studies, and underscores the need to build capacity and support people in communities.’

‘I think with the advent of this type of research, it will give people an idea of what's going on in the field so that they know where potentially they could identify and collect better evidence to add to this emerging evidence base. Ultimately it is quite a tricky space, and realistically when you are trying to do things that are good for your community, you have to make allowances and be pragmatic about how research is delivered.’

‘Overall, this was a huge and complex review that was really challenging to deliver but we’re so pleased we did,’ Natalie says. ‘I really have to hand it to the team though. It was their sheer persistence that delivered this review, and the reward now for us is having this really high quality piece of work that people from health services can use to show how effective their programs are. We wanted to support local services to advocate for themselves and now they can use this information as they need – either to show where they might need to make changes or to demonstrate that what they're doing is effective and benefits children, families and communities. They are really making a difference.’

Strobel NA, Chamberlain C, Campbell SK, Shields L, Bainbridge RG, Adams C, Edmond KM, Marriott R, McCalman J. Family‐centred interventions for Indigenous early childhood well‐being by primary healthcare services. Cochrane Database of Systematic Reviews 2022, Issue 12. Art. No.: CD012463. DOI: 10.1002/14651858.CD012463.pub2.

Written by  Shauna Hurley, Cochrane Australia 

 

Thursday, January 19, 2023
Muriah Umoquit

Celebrating Archie Cochrane

4 weeks 2 days ago

Cochrane is named in honour of Archie Cochrane, a British medical researcher who contributed greatly to the development of epidemiology as a science. 

Archie Cochrane is best known for his influential book, Effectiveness and Efficiency: Random Reflections on Health Services, published in 1972. The principles he set out in it so clearly were straightforward: he suggested that, because resources would always be limited, they should be used to provide equitably those forms of health care which had been shown in properly designed evaluations to be effective. In particular, he stressed the importance of using evidence from randomized controlled trials (RCTs) because these were likely to provide much more reliable information than other sources of evidence. Cochrane's simple propositions were soon widely recognised as seminally important - by lay people as well as by health professionals.

How can we have a rational health service if we don’t know which of the things being done in it are useful and which are useless or possibly even harmful? — Archie Cochrane

In 1979 he wrote, "It is surely a great criticism of our profession that we have not organised a critical summary, by specialty or subspecialty, adapted periodically, of all relevant randomised controlled trials." His challenge led to the establishment during the 1980s of an international collaboration to develop the Oxford Database of Perinatal Trials.

In 1987, the year before Cochrane died, he referred to a systematic review of RCTs of care during pregnancy and childbirth as "a real milestone in the history of randomized trials and in the evaluation of care", and suggested that other specialties should copy the methods used. His encouragement, and the endorsement of his views by others, led to the opening of the first Cochrane Centre (in Oxford, UK) in 1992 and the founding of  Cochrane in 1993.

Archie portrait made up of contributors pictures

Today Cochrane members and supporters come from 190 countries . We are researchers, health professionals, patients, carers, and people passionate about improving health outcomes for everyone, everywhere. Our global independent network gathers and summarizes the best evidence from research to help you make informed choices about treatment and we have been doing this for 30 years.

Thursday, January 12, 2023
Muriah Umoquit

Guidance for Colloquium abstract submissions

1 month ago

Cochrane London 2023: Forward together for trusted evidence
4-6 September 2023
Central London, UK

Cochrane UK is delighted to be hosting the  Cochrane Colloquium at the Queen Elizabeth II (QEII) Centre in London, UK from the 4 to 6 of September 2023, with satellite events and meetings on the 3rd September.

Cochrane is an international non-profit network that provides evidence-based scientific knowledge to improve healthcare for all people worldwide. Cochrane Reviews summarise all available research on a specific health question. They are up-to-date, follow a rigorous scientific methodology, and are free from commercial conflicts of interest. Health professionals, patients, and policy makers trust Cochrane Reviews for their healthcare decision-making. Cochrane works with researchers, health professionals, patients, policy makers, and media representatives from around the world to make Cochrane Reviews relevant and usable.

Cochrane holds an annual conference, known as a Colloquium, that brings together Cochrane researchers, clinical professionals, early career professionals, patients and carers, policymakers, and anyone interested in evidence synthesis and evidence-based healthcare. The events are a mix of keynote speakers, training opportunities, workshops, presentations, and a lively social and networking atmosphere. They are an exciting opportunity for a community of evidence synthesis enthusiasts to share, learn, and connect.  

We invite everyone to visit the website - colloquium2023.cochrane.org - for all information related to the colloquium as it's released, including submissions for abstracts and awards/prizes, registration, stipend applications, and the event programme.

The theme of the Colloquium is 'Forward together for trusted evidence', which explores the challenges for the future around the trustworthiness of healthcare information whilst also celebrating 30 years of producing trusted evidence. Today, we have launched guidance and recommendations to help you prepare in advance for your abstract submissions. The official call for abstracts will open on the 30 January 2023.

We invite abstract submissions for the following streams: producing trusted evidence; advocating for trusted evidence; informing health and care decisions; and co-production and working together. 

Catherine Spencer, Cochrane CEO said, “The Cochrane Colloquium will bring people together in one place to discuss, develop and promote Cochrane’s work. I am looking forward to a packed programme at my first colloquium and encourage you to start to think about your contributions now as the call for abstracts will be open soon.”

Martin Burton, Director of Cochrane UK, said: “We are really looking forward to receiving submissions of abstracts for London 2023.  We’d like to encourage everyone to start thinking about their contributions now – whether they are planning oral presentations, workshops or posters. We have prepared this guidance to help everyone to prepare their contributions in good time before submissions are formally opened on 30 January 2023.” 

  Wednesday, January 18, 2023
Muriah Umoquit

Cochrane seeks Support Officer - Flexible location, remote work

1 month 2 weeks ago

Location: Flexible location (remote working) – contract type dependent on location.
Specifications: Permanent position. Employment contract if successful applicant based in UK, Germany or Denmark. Consultancy contract in other locations.
Hours: Full-time (37.5 hours per week) or part-time (please specify desired working hours)
Salary: £30,000 per annum, prorata
Application Closing Date: Tuesday 17 January 2023 (Midnight GMT).

This role is an exciting opportunity to use your communication and problem-solving skills to make a difference in the field of healthcare research and publishing. 

Cochrane implemented Editorial Manager in 2021 as the editorial and production system for Cochrane Reviews. This role has a significant focus on supporting authors, editors and peer reviewers in using Editorial Manager for submission and peer review; and our linked system Convey for managing Declarations of Interest. Applications are particularly welcomed from candidates with experience of using these or similar systems.

The Cochrane Support team provides technical and user support to Cochrane editorial teams and review authors; and handle enquiries from members of the public about Cochrane’s work. We pride ourselves on our timely and coordinated support service, covering a broad range of areas, with a focus on Cochrane review-writing software and editorial processing and publication.

The team works closely with Cochrane’s Central Editorial Service and other related departments, to ensure accurate, consistent responses to queries on Cochrane technology, policies and methods.

Cochrane is a global, independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesizing research findings to produce the best available evidence on what can work, what might harm and where more research is needed. Our work is recognised as the international gold standard for high quality, trusted information.

Cochrane welcomes applications from a wide range of perspectives, experiences, locations, and backgrounds; diversity, equity and inclusion are key to their values.

How to apply: 

  • For further information on the role and how to apply, please click here  
  • The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples.
  • If you are applying for part-time work, please specify the number of hours you are interested in working.
  • Read our Recruitment Privacy Statement
  • Deadline for applications: Tuesday 17 January 2023 (12 midnight GMT)

 

Thursday, December 22, 2022 Category: Jobs
Muriah Umoquit
Checked
52 minutes 6 seconds ago
Subscribe to Cochrane News feed